There are 1105 resources available
704P - Exploring the optimal tumour mutational burden (TMB) cutoff for predicting efficacy of immune checkpoint inhibitors (ICI) in Chinese patients with advanced non-small-cell lung cancer (NSCLC): A territory-wide study
Presenter: Victor Lee
Session: Poster Display session
Resources:
Abstract
705P - Exploring the Impact of DDR pathway gene mutations on the immune microenvironment in non-small cell lung cancer patients
Presenter: Canfeng Lin
Session: Poster Display session
Resources:
Abstract
706P - Comparison of irinotecan/carboplatin versus etoposide/carboplatin for extended disease small cell lung cancer (ED-SCLC): A systematic review and meta-analysis of randomized controlled trials
Presenter: Zeeshan Afzal
Session: Poster Display session
Resources:
Abstract
707P - Investigation of prognostic factors in extensive stage small cell lung cancer with immune checkpoint inhibitors in first-line treatment using real-world data: Are immune-related adverse events also a prognostic factor?
Presenter: Tadashi Nishimura
Session: Poster Display session
Resources:
Abstract
709P - The impact of antibiotic use on ICI plus chemotherapy versus chemotherapy in NSCLC patients with PD-L1 expression of 1% to 49%
Presenter: Yuji Toyota
Session: Poster Display session
Resources:
Abstract
710P - Retrospective study on the tolerability of anti-PD-L1 antibody plus platinum-etoposide for elderly patients with extensive-stage small-cell lung cancer based on body mass index
Presenter: Yuto Terashima
Session: Poster Display session
Resources:
Abstract
711P - Prognostic impact of oligometastasis in elderly patients with extensive-stage small cell lung cancer
Presenter: Daisuke Morinaga
Session: Poster Display session
Resources:
Abstract
712P - Efficacy and safety evaluation of first-line immunotherapy combing with chemotherapy followed by local consolidation radiotherapy for stage IV non-small cell lung cancer
Presenter: Li-Jun Tian
Session: Poster Display session
Resources:
Abstract
713P - Multicenter observational study on combination immunotherapy for extensive-stage small cell lung cancer
Presenter: Yoshihiro Masui
Session: Poster Display session
Resources:
Abstract
714P - Real-world treatment pattern and clinical outcome in Chinese NSCLC patients with KRAS G12C mutation
Presenter: Lan Shen
Session: Poster Display session
Resources:
Abstract